TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Rechon Life Science AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
492,266
|
367,251
|
298,077 |
Financial expenses |
3,171
|
1,226
|
1,026 |
Earnings before taxes |
57,164
|
56,996
|
28,537 |
EBITDA |
79,730
|
73,626
|
42,183 |
Total assets |
369,072
|
309,265
|
276,639 |
Current assets |
207,660
|
159,166
|
131,078 |
Current liabilities |
102,193
|
75,502
|
51,868 |
Equity capital |
205,607
|
160,492
|
127,566 |
- share capital |
27,900
|
26,051
|
26,859 |
Employees (average) |
249
|
212
|
184 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
55.7%
|
51.9%
|
46.1% |
Turnover per employee |
1,977
|
1,732
|
1,620 |
Profit as a percentage of turnover |
11.6%
|
15.5%
|
9.6% |
Return on assets (ROA) |
16.3%
|
18.8%
|
10.7% |
Current ratio |
203.2%
|
210.8%
|
252.7% |
Return on equity (ROE) |
27.8%
|
35.5%
|
22.4% |
Change turnover |
98,956
|
78,132
|
-1,286 |
Change turnover % |
25%
|
27%
|
0% |
Chg. No. of employees |
37
|
28
|
9 |
Chg. No. of employees % |
17%
|
15%
|
5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.